Oral Feeding of Probiotic Bifidobacterium infantis: Colonic Morphological Changes in Rat Model of TNBS-Induced Colitis

Scientifica

Volumn 2016, Issue , 2016, Pages

  Javed, Najma H ^a   Alsahly, Musaad B ^a   Khubchandani, Jagdish ^a  

^a BALL STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84979017921     PISSN: None     EISSN: 2090908X     Source Type: Journal    
DOI: 10.1155/2016/9572596     Document Type: Article

References (26)

1. S. H. Rhee, C. Pothoulakis, and E. A. Mayer, "Principles and clinical implications of the brain-gut-enteric microbiota axis," Nature Reviews Gastroenterology and Hepatology, vol. 6, no. 5, pp. 306-314, 2009.
2. D. Damaskos and G. Kolios, "Probiotics and prebiotics in inflammatory bowel disease: microflora 'on the scope'," British Journal of Clinical Pharmacology, vol. 65, no. 4, pp. 453-467, 2008.
3. A. M. O'Hara and F. Shanahan, "The gut flora as a forgotten organ," EMBO Reports, vol. 7, no. 7, pp. 688-693, 2006.
4. R. B. Sartor, "Does Mycobacteriumaviumsubspecies paratuberculosis cause Crohn's disease?" Gut, vol. 54, no. 7, pp. 896-898, 2005.
5. L. Sherwood, Human Physiology: From Cells to Systems, Books/Cole, Cengage Learning, Belmont, Calif, USA, 7th edition, 2010.
6. J. B. Ewaschuk, H. Diaz, L. Meddings et al., "Secreted bioactive factors from Bifidobacterium infantis enhance epithelial cell barrier function," American Journal of Physiology-Gastrointestinal and Liver Physiology, vol. 295, no. 5, pp. G1025-G1034, 2008.
7. R. J. Boyle, R. M. Robins-Browne, and M. L.K. Tang, "Probiotic use in clinical practice: what are the risks?" American Journal of Clinical Nutrition, vol. 83, no. 6, pp. 1256-1264, 2006.
8. N. Javed, D. Furman, and J. Khubchandani, "The regulatory effects of Bifidobacterium infantis on the secretomotor activity of the enteric nervous system," Chronicles of Young Scientists, vol. 4, no. 2, pp. 114-120, 2013.
9. C. Fiocchi, "Inflammatory bowel disease: etiology and pathogenesis," Gastroenterology, vol. 115, no. 1, pp. 182-205, 1998.
10. G. Aragon, D. B. Graham, M. Borum, and D. B. Doman, "Probiotic therapy for irritable bowel syndrome," Gastroenterology and Hepatology, vol. 6, no. 1, pp. 39-44, 2010.
11. L. Peran, D. Camuesco, M. Comalada et al., "A comparative study of the preventative effects exerted by three probiotics, Bifidobacterium lactis, Lactobacillus casei and Lactobacillus acidophilus, in the TNBS model of rat colitis," Journal of Applied Microbiology, vol. 103, no. 4, pp. 836-844, 2007.
12. L. Peran, D. Camuesco, M. Comalada et al., "Preventative effects of a probiotic, Lactobacillus salivarius ssp. salivarius, in the TNBS model of rat colitis," World Journal of Gastroenterology, vol. 11, no. 33, pp. 5185-5192, 2005.
13. L. Zheng, Z.Q. Gao, and S.X. Wang, "Achroniculcerative colitis model in rats," World Journal of Gastroenterology, vol. 6, no. 1, pp. 150-152, 2000.
14. W. Yue-Meng, Z. You-Qing, X. Bing, and L. Jun, "Treating TNBS-induced colitis in rats with probiotics," Turkish Journal of Gastroenterology, vol. 22, no. 5, pp. 486-493, 2011.
15. A. F. Stucchi, S. Shofer, S. Leeman et al., "NK-1 antagonist reduces colonic inflammation and oxidative stress in dextran sulfate-induced colitis in rats," American Journal of Physiology-Gastrointestinal and Liver Physiology, vol. 279, no. 6, pp. G1298-G1306, 2000.
16. D.-M. McCafferty, M. Miampamba, E. Sihota, K. A. Sharkey, and P. Kubes, "Role of inducible nitric oxide synthase in trinitrobenzene sulphonic acid induced colitis in mice," Gut, vol. 45, no. 6, pp. 864-873, 1999.
17. J. Guzman, J. G. Yu, Z. Suntres et al., "ADOA3Ras a therapeutic target in experimental colitis: proof by validated high-density oligonucleotide microarray analysis," Inflammatory Bowel Diseases, vol. 12, no. 8, pp. 766-789, 2006.
18. X.-Z. Shi, J. H. Winston, and S. K. Sarna, "Differential immune and genetic responses in rat models of Crohn's colitis and ulcerative colitis," American Journal of Physiology-Gastrointestinal and Liver Physiology, vol. 300, no. 1, pp. G41-G51, 2011.
19. D. Jonkers and R. Stockbrügger, "Probiotics and inflammatory bowel disease," Journal of the Royal Society of Medicine, vol. 96, no. 4, pp. 167-171, 2003.
20. T. Yamada, S. Marshall, R. D. Specian, and M. B. Grisham, "A comparative analysis of two models of colitis in rats," Gastroenterology, vol. 102, no. 5, pp. 1524-1534, 1992.
21. H. Arndt, J. Schölmerich, and K.-D. Palitzsch, "Lactulose and neomycin attenuate leukocyte-endothelial cell adhesion in an animal model of inflammatory bowel disease," European Journal of Gastroenterology and Hepatology, vol. 10, no. 4, pp. 339-343, 1998.
22. S. Macfarlane, E. Furrie, A. Kennedy, J. H. Cummings, and G. T. Macfarlane, "Mucosal bacteria in ulcerative colitis," The British Journal of Nutrition, vol. 93, supplement 1, pp. S67-S72, 2005.
23. C. Caballero-Franco, K. Keller, C. De Simone, and K. Chadee, "The VSL#3 probiotic formula induces mucin gene expression and secretion in colonic epithelial cells," American Journal of Physiology-Gastrointestinal and Liver Physiology, vol. 292, no. 1, pp. G315-G322, 2007.
24. M. Kruschewski, T. Foitzik, A. Perez-Cantó, A. Hũbotter, and H. J. Buhr, "Changes of colonic mucosal microcirculation and histology in two colitis models: an experimental study using intravital microscopy and a new histological scoring system," Digestive Diseases and Sciences, vol. 46, no. 11, pp. 2336-2343, 2001.
25. R. N. Fedorak, "Probiotics in the management of ulcerative colitis," Gastroenterology & Hepatology, vol. 6, no. 11, pp. 688-690, 2010.
26. J. H. Cummings, G. T. Macfarlane, and S. Macfarlane, "Intestinal bacteria and ulcerative colitis," Current Issues in Intestinal Microbiology, vol. 4, no. 1, pp. 9-20, 2003.